About this trial
This is a qualitative and quantitative study that seeks to obtain information from patients with degenerative mitral valve prolapse and providers regarding factors important in deciding between surgical mitral valve repair (MVR) and transcatheter edge-to-edge repair (TEER). Findings from this study will provide data that can be used to develop decision aids that can assist patients in decision making between these two therapies and assist providers in integrating shared decision making the within the multidisciplinary heart valve team.
Eligibility criteria
Qualifiers
Age 21 years and older
Diagnosis of degenerative mitral valve regurgitation
Disqualifiers
Non-English speaking
Unable to consent on own behalf
Previous mitral surgery
Trial design
Treatments tested in this trial
- Focus Groups/Quantitative Survey for Patients
- Focus Group/Quantitative Survey for HCPs
- Qualitative Focus Group
Treatment groups
Sponsors and collaborators
Northwell Health
Lead sponsor
West Virginia University
Collaborator
Cedars-Sinai Medical Center
Collaborator
The Cleveland Clinic
Collaborator
University of Kansas Medical Center
Collaborator
Saint Luke's Mid America Heart Institute
Collaborator